VAT Group AG earnings date
Want to see CH:VACN full AI Analyst Report?
VAT Group AG (VACN) Q2 2026 Earnings Report
CH:VACN Q2 2026 EPS Results
- Actual EPS
- CHF 3.30
- Consensus EPS
- CHF 3.24
- Beat/Miss
- Beat by +CHF 0.06
- One Year Ago EPS
- CHF 3.52
CH:VACN Q2 2026 Revenue Results
- Actual Revenue
- CHF 511.89M
- Expected Revenue
- CHF 289.35M
- Beat/Miss
- Beat by +CHF 222.54M
- YoY Revenue Growth
- -8.26%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 07/22/2026
- Time
- Before Open
- Conference Call
- Wednesday, July 22, 2026
VAT Group AG's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
The call conveyed a strongly positive operational and market momentum: record orders, rapid factory output ramp (32% Q/Q) and a healthy order book (book-to-bill 1.7x) underpin near-term growth and confidence in achieving a >CHF 450m quarterly run rate by year-end. Innovation metrics (60 specification wins, 7% R&D spend) and the strategic acquisition of Atonarp support a longer-term technology expansion beyond core valves. Offsetting risks include front-loaded ramp costs weighing on H1 EBITDA (29.0% vs 29.6%), supply-chain and component constraints, FX/commodity headwinds, and limited near-term financial visibility for the Atonarp asset. Management expects operational leverage in H2 and a record 2026 for orders, sales and free cash flow, but acknowledged uncertainty in 2027 visibility.
Management guided Q3 sales of CHF 355–385 million and reiterated it is on track to reach a quarterly factory output run‑rate of >CHF 450 million by year‑end (annualized ≈CHF 1.8bn), with current market consensus around CHF 1.3bn and an expected >50% increase in sales into H2; they said 2026 should be a record year for orders, sales and free cash flow. Guidance was backed by a strong order picture (Q2 record orders >CHF 500m; Q2 orders +40% q‑q, +102% y‑y; order book +50% since last report and +120% y‑y; book‑to‑bill 1.7x; ~2/3 of the order book set to convert to sales in 3–4 months). On profitability they reported H1 EBITDA of 29% (H1 gross margin 66.6%) and expect full‑year EBITDA to finish in the “upper half of the lower half” of their guidance band while anticipating second‑semester EBITDA to be in the “upper half of the upper half” as operating leverage materializes.
- Record Order Intake in Q2Q2 order intake reached a record CHF 500 million; Q2 orders were up 40% sequentially and up ~102% year-over-year. The order book increased ~50% since last reporting and >120% versus last year, with a book-to-bill ratio of 1.7x.
- Strong First-Half Order GrowthFirst-half orders increased 75% year-on-year, reflecting broad-based confidence in a sustained semiconductor growth cycle driven by wafer fab equipment demand.
- Rapid Factory Output RampQ2 output rose 32% quarter-over-quarter, exceeding prior target of 20%-30% per quarter. Company remains on track to reach a quarterly factory output run rate of >CHF 450 million by year-end.
- Workforce and Capacity ExpansionAdded >700 employees in H1 across Malaysia, Switzerland, and Romania (approximately 22% new colleagues referenced), with ~85% of hires in manufacturing roles and significant capacity expansion in Malaysia (Malaysia factory utilization ~80%-85%; Switzerland ~70%).
- Solid Profitability Metrics Despite Ramp CostsGross profit declined 7% year-on-year but gross margin improved to 66.6% from 65.5% a year ago. H1 EBITDA margin was 29.0% (versus 29.6% prior year) despite frontloaded ramp-related expenses.
- Innovation Momentum and Specification WinsInvested ~7% of sales in R&D in H1; secured 60 specification wins in first six months and maintain >130 development projects, signaling strong technology leadership and future revenue pipeline.
- Adjacencies and Service Contributing to GrowthSemiconductor new valve sales grew 134% year-over-year; Advanced Industrials orders up 36% YoY; adjacencies showing 5% growth and global service/consumables also contributing as fab utilization increases.
- Strategic Acquisition of AtonarpSigned SPA to acquire Atonarp for its miniaturized mass spectrometry (Aston) technology for real-time in-chamber molecular sensing; positioned as a long-term capability expansion into process sensing and analytics to support sub-2nm and beyond. Management expects meaningful bottom-line contribution by end of decade and modest incremental R&D (~0.5% of revenue).
CH:VACN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | 3.62- | 3.62 | ― | ― |
| Jul 22, 2026 | 2026 (Q2) | 3.243.30 | 3.52 | -6.22% (-0.22) | |
| Mar 03, 2026 | 2025 (Q4) | 3.533.62 | 3.93 | -7.72% (-0.30) | |
| Jul 23, 2025 | 2025 (Q2) | 4.773.52 | 3.13 | 12.32% (+0.39) | |
| Mar 04, 2025 | 2024 (Q4) | 3.733.93 | 3.2 | 22.57% (+0.72) | |
| Jul 18, 2024 | 2024 (Q2) | 3.033.13 | 2.81 | 11.49% (+0.32) | |
| Mar 05, 2024 | 2023 (Q4) | 3.203.20 | 5.3 | -39.55% (-2.10) | |
| Jul 27, 2023 | 2023 (Q2) | 3.002.81 | 4.92 | -42.89% (-2.11) | |
| Mar 02, 2023 | 2022 (Q4) | 5.235.30 | 3.94 | 34.45% (+1.36) | |
| Aug 04, 2022 | 2022 (Q2) | 3.694.92 | 3.31 | 48.64% (+1.61) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.


